Dear Research Advocate, Phase 3 enrollment is now underway for a number of COVID-19 vaccine clinical trials. That science has moved so quickly from first identification of the virus to Phase 3 trials, speaks to remarkable public-private sector collaboration. It also speaks to the absolute necessity of taxpayer investment in basic, discovery science over many years; a lesson we must not ignore as we plan responses to the pandemics that will surely follow. To help move the massive trial enrollment process along, NIH has launched the COVID-19 Prevention Trials Network (COVPN), merging networks already funded by NIAID for HIV and other infectious disease trials. Each of the Phase 3 clinical...
Tags21st Century Cures advocacy Advocacy Awards AHRQ appropriations biomedical research Campaign for Cures cancer CDC COVID-19 FDA global health health research innovation Mary Woolley medical research mental health National Health Research Forum National Institutes of Health NIH NSF public health Public Health Thank You Day research Research!America science sequestration supplemental funding weekly letter weekly message
How Can I Help?
Other Advocacy Tools:
Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor